Of note, nearly half of the serum samples (42.4%) exhibited FGFBP1 levels below the detection limit (23.4 pg/ml) for ELISA, suggesting that FGFBP1 may hold significant therapeutic potential in ALI. Here, FGFBP1 is linked to acute respiratory distress syndrome.